Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Mar 18, 2025

SELL
$72.96 - $84.0 $729,599 - $840,000
-10,000 Closed
0 $0
Q2 2024

Mar 18, 2025

SELL
$67.33 - $77.71 $336,650 - $388,549
-5,000 Reduced 33.33%
10,000 $770 Million
Q3 2023

Mar 18, 2025

SELL
$50.19 - $54.68 $50,190 - $54,680
-1,000 Reduced 6.25%
15,000 $792 Million
Q4 2022

Mar 18, 2025

BUY
$39.56 - $47.22 $79,120 - $94,440
2,000 Added 14.29%
16,000 $740 Million
Q2 2021

Mar 18, 2025

BUY
$38.58 - $44.24 $540,120 - $619,360
14,000 New
14,000 $599 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $144B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Criteria Caixa, S.A.U. Portfolio

Follow Criteria Caixa, S.A.U. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Criteria Caixa, S.A.U., based on Form 13F filings with the SEC.

News

Stay updated on Criteria Caixa, S.A.U. with notifications on news.